All Philips HeartStart defibrillator products are affected by this injunction, with specific exceptions as noted in the Consent Decree.
At this time, subject to limitations and conditions, Philips is permitted to continue manufacture and shipping of HeartStart Home and HeartStart OnSite automated external defibrillators in order to meet public health needs.
Under certain conditions, Philips may also manufacture and ship Philips HeartStart FR3 Automated External Defibrillators (AEDs) to customers who have standardized on HeartStart FR3 devices.
Philips may continue to provide necessary consumables and accessories for Philips defibrillator products, without restriction.
Philips may continue to service and upgrade existing devices, as well as continue R&D efforts and participation in clinical trials.
Our focus remains on rapidly and effectively returning Philips’ defibrillator manufacturing sites to consistent compliance with quality regulations, as we renew our culture of quality.